Hot Stocks

Hot stocks are not about hype. They emerge when powerful themes, policy shifts, and capital flows converge. InvestorPlace analysts track fast-moving market narratives, especially in technology, AI, and infrastructure, to identify stocks drawing outsized attention and explain what is really driving those moves.

JetBlue Airways Stock Will Chop Around but Trend Higher

By David Moadel, InvestorPlace Contributor
JBLU stock holders' success depends on a recovery in the airline industry and, more generally, a vaccine and an economic turnaround.

Genius Brands Stock isn’t a Smart Pick

By Marie Brodbeck, InvestorPlace Contributor
While the story behind GNUS might sound promising, investors need to be cautious with this penny stock which looks to be heading lower

Aurora Cannabis: Should Contrarian Investors Buy ACB Stock In September?

By Tezcan Gecgil, InvestorPlace Contributor
There may not yet be respite for investors in ACB stock yet

Jumia Technologies Stock Is a Flawed E-commerce Investment

By David Moadel, InvestorPlace Contributor
The momentum in JMIA stock is decidedly downwards as investors must accept that not every e-commerce company will be a runaway success.

Investors Should Be Realistic with Tilray Stock

By Josh Enomoto, InvestorPlace Contributor
On paper, Tilray stock is supported by attributes that make it attractive during a pandemic. But the details tell a different story.

What to Do With Luckin Stock After Its Recent Bounce

By Ian Bezek, InvestorPlace Contributor
Is the "Starbucks of China" still viable? If the company's cash is real, disgraced Luckin stock may be able to mount a comeback.

No Need to Rush Into CureVac Stock After Massive IPO Pop

By InvestorPlace Research Staff
CVAC stock is one of many intriguing plays on a Covid-19 vaccine. But 300% above the IPO price, investors seemingly have better options.

Understand the Science Before Deciding on Sorrento Therapeutics

By Josh Enomoto, InvestorPlace Contributor
SRNE stock was one of the top performers of this year. But just as quickly, shares have faded, and I'm not sure its Covid-19 pipeline will pan out.

Ford Is Still Undervalued, But its New CEO May Change This

By Mark R. Hake, CFA
Ford is still undervalued but its new CEO may change things. I think F stock is worth at least $8.40 if it resumes its 60-cent annual dividend next year.

With a Little Patience, ZoomInfo Stock Will Could Be a Long-Term Winner

By Tom Taulli, InvestorPlace Contributor
The company was one of the first tech IPOs after the pandemic hit. But ZoomInfo stock could get overshadowed.

Landcadia Holdings Stock Is a Golden Nugget of an Opportunity

By David Moadel, InvestorPlace Contributor
DraftKings isn't the only online gaming company out there. Check out an intriguing competitor and decide whether LCA stock is worth your time.

Southwest Airlines Is in Exclusive Company But Will It Stay There?

By Will Ashworth, InvestorPlace Contributor
Southwest Airlines is one of three airlines with investment-grade bonds. LUV stock needs it to stay that way or it's headed lower.

These Tiger Lake Specs Make Intel Stock Look Much More Attractive

By Larry Ramer, InvestorPlace Contributor
Intel's new Tiger Lake chips utilize advanced technologies that should enable it to stop losing share to AMD, boosting Intel stock.

The Tech Wreck Is Just What Advanced Micro Devices Needed

By Chris Markoch, InvestorPlace Contributor
Advanced Micro Devices is one of the best performing stocks of 2020. That's why investors should celebrate the dip in AMD stock price as a great buying opportunity.

Roku Is a Winner Amid the Tech Weakness

By Larry Ramer, InvestorPlace Contributor
Roku's outlook remains very bright, and Roku stock is not overvalued. But investors may want to wait before pulling the trigger.

Lay off Spartan Energy Stock Until After the EV Bubble Pops and Prices Decline

By Thomas Niel, InvestorPlace Contributor
So, what's the play? SPAQ stock may be a great opportunity if shares fall back to their offering price (around $10 per share). But, in the meantime, it's best to take a "wait-and-see approach" for now.

Why Science and Economics Might Justify CureVac

By Josh Enomoto, InvestorPlace Contributor
Amid a sea of red ink in the Covid-19 vaccine space, CureVac stock has gone against the grain, printing some sizable gains. Can investors trust the momentum for CureVac?

Lyft rides recover slightly in August, remain down 53% from last year

By Robert Lakin, InvestorPlace Contributor
It’s been a rough year for holders of Lyft stock. The ride-hailing company said August trips showed some improvement.

Bank of America Could Benefit From Rotation From Tech to Financials

By Tezcan Gecgil, InvestorPlace Contributor
September may be too soon to get back into BAC stock, but a sector rotation could set stage for a move in.
Load More Articles